Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas

Biochemical and Biophysical Research Communications

Volumn 299, Issue 4, 2002, Pages 517-524

  Gallo, Oreste ^a   Fabbroni, Valentina ^a   Sardi, Iacopo ^a   Magnelli, Lucia ^a   Boddi, Vieri ^a   Franchi, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiogenesis; Cyclooxygenase 2; Head and neck cancer; Inducible nitric oxide

Indexed keywords

CYCLIC GMP; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; GUANYLATE CYCLASE INHIBITOR; LIPOPOLYSACCHARIDE; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR;

ANGIOGENESIS; ARTICLE; CARCINOMA CELL; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESCHERICHIA COLI; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CYCLIC GMP; CYCLOOXYGENASE 2; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; ISOENZYMES; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; S-NITROSO-N-ACETYLPENICILLAMINE; SIGNAL TRANSDUCTION; STATISTICS; TUMOR CELLS, CULTURED; UP-REGULATION;

ESCHERICHIA COLI;

EID: 0036924863     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02683-9     Document Type: Article

References (39)

1. M.M. Taketo, Cyclooxygenase-2 inhibitors in tumorigenesis, J. Natl. Cancer Inst. 90 (1998) 1069-1080.
2. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, S.A. Baylis, P. Rhodes, K. Westmore, P.C. Emson, S. Moncada, Roles of nitric oxide in tumor growth, Proc. Natl. Acad. Sci. USA 92 (1995) 4392-4396.
3. M. Young, Eicosanoids and the immunology of cancer, Cancer Metast. Rev. 13 (1994) 337-348.
4. 2 in human colon cancer cells, Cancer Res. 58 (1998) 362-366.
5. H. Sawaoka, S. Kawano, S. Tsuji, M. Tsuji, E.S. Gunawan, Y. Takei, H. Nagano, M. Hori, Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice, Am. J. Physiol. 274 (1998) 1061-1067.
6. M.P. Murphy, Nitric oxide and cell death, Biochim. Biophys. Acta 1411 (1999) 401-414.
7. M. Tsujii, S. Kawano, S. Tsuji, H. Sawaoka, M. Hori, R.N. Du Bois, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell 93 (1998) 705-716.
8. 2-expressing human carcinoma cells, Nat. Med. 12 (1998) 1371-1376.
9. O. Gallo, E. Masini, L. Morbidelli, A. Franchi, I. Fini Storchi, W.A. Vergari, M. Ziche, Angiogenesis and tumor progression are under the control of nitric oxide in head and neck cancer, J. Natl. Cancer Inst. 90 (1998) 587-596.
10. J.R. Vane, J.A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, D.A. Willoughby, Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation, Proc. Natl. Acad. Sci. USA 91 (1994) 2046-2050.
11. D. Salvemini, Regulation of cyclooxygenase enzymes by nitric oxide, Cell. Mol. Life Sci. 53 (1997) 576-582.
12. D.C. Goodwin, L.M. Landino, L.J. Marnett, Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis, FASEB J. 13 (1999) 1121-1136.
13. K.T. Wilson, S. Fu, K.S. Ramanujam, S.J. Meltzer, Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas, Cancer Res. 58 (1998) 2929-2934.
14. M.A. Rahman, D.K. Dhar, E. Yamaguchi, S. Maruyama, T. Sato, H. hayashi, T. Ono, A. Yamanoi, H. Kohno, N. Nagasue, Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: Possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases, Clin. Cancer Res. 7 (2001) 1325-1332.
15. R.J. Bing, M. Miyataka, K.A. Rich, N. Hanson, X. Wang, H.D. Slosser, S.R. Shi, Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer, Clin. Cancer Res. 7 (2001) 3385-3392.
16. A. Franchi, M. Santucci, E. Masini, I. Sardi, M. Paglierani, O. Gallo, Matrix metalloproteinase 1, 2 and 9 expression in head and neck cancer: correlation with p53 status, iNOS activity and angiogenesis, Cancer 95 (2002) 1902-1910.
17. O. Gallo, A. Franchi, L. Magnelli, I. Sardi, A. Vannacci, V. Boddi, V. Chiarugi, E. Masini, Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis, Neoplasia 3 (2001) 53-61.
18. K.W. Rosbe, J.W. Mims, J. Prazma, P. Petrusz, A. Rose, A.F. Drake, Immunohistochemical localization of nitric oxide synthase activity in upper respiratory epithelium, Laryngoscope 106 (1996) 1075-1079.
19. P. Demoly, L. Crampette, B. Lebel, A.M. Campbell, M. Mondain, J. Bousquet, Expression of cyclo-oxygenase 1 and 2 proteins in upper respiratory mucosa, Clin. Exp. Allergy 28 (1998) 278-283.
20. N. Weidner, J.P. Semple, W.R. Welch, J. Folkman, Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma, New Engl. J. Med. 324 (1991) 1-8.
21. D. Salvemini, V. Mollace, A. Pistelli, E. Anggard, J. Vane, Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide, Proc. Natl. Acad Sci. USA 89 (1992) 982-986.
22. P. Gentilini, G. LaL, E. Meacci, G. La Villa, F. Cominelli, M. Pinzani, G. Buzzelli, Effects of OKY046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites, Gastroenterology 94 (1988) 1470-1477.
23. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-253.
24. X. Lu, W. Xie, D. Reed, W.S. Bradshaw, D.L. Simmons, Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts, Proc. Natl. Acad. Sci. USA 92 (1995) 7961-7965.
25. M.W. Owens, S.A. Milligan, M.B. Grisham, Nitric oxide synthesis by rat pleural mesothelial cells: Induction by growth factors and lipopolysaccharide, Exp. Cell. Res. 21 (1995) 731-742.
26. D.N. Watkins, M.J. Garlepp, P.J. Thompson, Regulation of the inducible cyclooxygenase pathway in human cultured airway epithelial (A549) cell by nitric oxide, Br. J. Phramacol. 121 (1997) 1482-1488.
27. L.C. Hamilton, T.D. Warner, Interactions between inducible isoforms of nitric oxide synthase and cyclooxygenase in vivo: Investigations using the selective inhibitors, 1400 W and celecoxib, Br. J. Pharmacol. 125 (1998) 335-340.
28. S. Nogawa, C. Forster, F. Zhang, M. Nagayama, M.E. Ross, C. Iadecola, Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia, Proc. Natl. Acad. Sci. USA 95 (1998) 10966-10971.
29. 2 by human cultured astroglial cells, Br. J. Pharmacol. 124 (1998) 742-746.
30. L. Chen, M.N. Salafranca, J.L. Mehta, Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets, Am. J. Physiol. 273 (Heart Circ. Physiol. 42) (1997) H1854-H1859.
31. A. Parenti, L. Morbidelli, X.L. Cui, J.G. Douglas, J.D. Hood, H.J. Granger, F. Ledda, M. Ziche, Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium, J. Biol. Chem. 271 (1998) 4220-4226.
32. M.K. Jones, H. Wang, B.M. Peskar, E. Levin, R.M. Itani, I.J. Sarfeh, A.S. Tarnawski, Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing, Nat. Med. 5 (1999) 1418-1423.
33. 2 biosynthesis in macrophages, J. Leukoc. Biol. 65 (1999) 792-799.
34. T. Testkuta, D. Daphna-Iken, B.W. Miller, Z. Guan, L.D. Baier, A.R. Morrison, Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells, J. Clin. Invest. 97 (1996) 2051-2056.
35. L.C. Jadeski, P.K. Lala, Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors, Am. J. Pathol. 155 (1999) 1381-1390.
36. H. Sawaoka, S. Tsuji, M. Tsujii, E.S. Gunawan, Y. Sasaki, S. Kawano, M. Hori, Cyclooxygenase inhibitors suppressangiogenesis and reduce tumor growth in vivo, Lab. Invest. 79 (1999) 1469-1477.
37. S. Ambs, S.P. Hussain, C.C. Harris, Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression, FASEB J. 11 (1997) 443-448.
38. O. Gallo, I. Sardi, M. Masini, A. Franchi, Re: Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer, J. Natl. Cancer Inst. 91 (1999) 1509-1510.
39. G. Chan, J.O. Boyle, E.K. Yang, F. Zhang, P.G. Sacks, J.P. Shah, D. Edelstein, R.A. Soslow, A.T. Koki, B.M. Woerner, J.L. Masferrer, A.J. Dannenberg, Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck, Cancer Res. 59 (1999) 991-994.